David Rosen – MREO history
- Issuer:
- MEREO BIOPHARMA GROUP PLC
- Quarters tracked:
- 16 (Q3 2022 → Q2 2026)
- Current shares:
- 15,307,347
- Current value:
- $4.86M
- Peak shares:
- 15,307,347 (Q2 2024)
- Overall change:
- +48%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q2 2026 | 15,307,347 | $4.86M | $0.32 | 0 | 0% |
| Q1 2026 | 15,307,347 | $5.05M | $0.33 | 0 | 0% |
| Q4 2025 | 15,307,347 | $6.38M | $0.42 | 0 | 0% |
| Q3 2025 | 15,307,347 | $31.53M | $2.06 | 0 | 0% |
| Q2 2025 | 15,307,347 | $41.48M | $2.71 | 0 | 0% |
| Q1 2025 | 15,307,347 | $34.44M | $2.25 | 0 | 0% |
| Q4 2024 | 15,307,347 | $53.58M | $3.50 | 0 | 0% |
| Q3 2024 | 15,307,347 | $62.91M | $4.11 | 0 | 0% |
| Q2 2024 | 15,307,347 | $55.11M | $3.60 | +1,754,350 | +13% |
| Q1 2024 | 13,552,997 | $44.73M | $3.30 | 0 | 0% |
| Q4 2023 | 13,552,997 | $31.31M | $2.31 | +1,936,877 | +17% |
| Q3 2023 | 11,616,120 | $14.98M | $1.29 | 0 | 0% |
| Q2 2023 | 11,616,120 | $15.33M | $1.32 | +1,250,000 | +12% |
| Q1 2023 | 10,366,120 | $7.33M | $0.71 | 0 | 0% |
| Q4 2022 | 10,366,120 | $7.78M | $0.75 | 0 | 0% |
| Q3 2022 | 10,366,120 | $8.93M | $0.86 | — | NEW |